PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-04-14 (1)

Date Title Company
14-Apr-2022 Genmab and AbbVie Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) From Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) Businesswire